Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility

MUMBAI, India, Sept. 29, 2026 // -- Piramal Pharma Solutions ("PPS"), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. ("PPL") (NSE:PPLPHARMA) (BSE: 543635), today announced that its Aurora, Canada drug substance site has received…